Moving forward, research may increasingly focus on DKD and membranous nephropathy (MN), potentially emphasizing the NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) pathway. This evidence concerns the gene NFKB1 and membranous glomerulonephritis.